Detecting rare mutations associated with cancer risk.

Abstract excerpt

For more than a decade, investigators have been searching for a means of determining the risk of individuals developing cancer by detecting rare oncogenic mutations. The accumulation of mutations and the clonal evolvement of tumors provide opportunities for monitoring disease development and intervening prior to the presentation of clinical symptoms, or determining the risk of disease relapse during remission. A...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Body Fluids
• Share to Mutation
• Share to Neoplasms